Pyrilutamide (KX-826) is a first-in-class small molecule AR antagonist in development for the treatment of androgenetic alopecia. Kintor Pharmaceutical is conducting Phase II clinical trials in male and female androgenetic alopecia subjects in the United States and China. The raw material pyrilutamide used in PyriPure was tested and confirmed >99% pure by a 3rd party. […]